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ABSTRACT: The remarkable diversity of the self-assembly behavior
of PEG−peptides is reviewed, including self-assemblies formed by
PEG−peptides with β-sheet and α-helical (coiled-coil) peptide
sequences. The modes of self-assembly in solution and in the solid
state are discussed. Additionally, applications in bionanotechnology
and synthetic materials science are summarized.
1. INTRODUCTION
Attachment of PEG to peptides or proteins, so-called
PEGylation, oﬀers improved water solubility and stability as
well as reduced clearance through the kidneys, leading to a
longer circulation time.1 Several reviews on polymer−peptide
conjugates discuss examples of self-assembling PEG−peptide
conjugates,2−4 and reviews discussing applications of PEGyla-
tion of peptides and proteins for applications in biotechnology
are available.5−8
This review is focused on PEG−peptide conjugates and does
not cover methods of protein PEGylation or applications of
PEGylated proteins. These topics have been extensively
reviewed elsewhere.9−12 The application of PEGylation in
drug delivery has been reviewed, including lists of commercially
developed PEGylated proteins for therapeutics.5,7,8,13 General
reviews on polymer−peptide conjugates also feature discussion
of PEG−peptide conjugates.1,14−16 A book on bioconjugation
techniques17 discusses many chemistries that can be used to
prepare PEG−peptide conjugates. This review focuses on the
self-assembly of PEG−peptide conjugates, with a brief
discussion of the relevant preparation chemistries, as these
are reviewed in more detail in the above-mentioned
publications.
The following notation is used here for PEG with diﬀerent
molar mass: in PEGxk, x denotes the molar mass in kilograms
per mole, and in PEGn, n denotes the average degree of
polymerization. Amino acids are abbreviated with single- or
three-letter codes.
This review is organized as follows. Methods to synthesize
PEG−peptide conjugates are outlined in Section 2. Sections 3
and 4 discuss the self-assembly of PEG−peptide diblock
conjugates containing β-sheet or α-helical peptides, respec-
tively. The self-assembly of PEG−peptide conjugates with more
complex triblock and multiblock architectures is reviewed in
Section 5. In Section 6, the class of PEG−peptides containing
synthetic polypeptides such as poly(γ-benzyl L-glutamate)
(PBLG) is considered. PEG crystallization eﬀects on self-
assembly are examined in Section 7. The ﬁnal sections
introduce selected applications of PEG−peptides. Section 8
concerns enzyme-responsive PEG−peptide conjugates, whereas
Section 9 summarizes studies on PEG−peptides for drug
delivery. Lastly, a brief summary and outlook are included in
Section 10.
2. SYNTHETIC METHODS
2.1. Coupling. 2.1.1. Coupling Chemistries. Examples of
some of the common coupling chemistries are shown in Figure
1. As will become apparent in the following discussion, this is
not an exhaustive list of methods used to link PEG polymers
and peptides.
Amine groups at the N terminus or on lysine side chains are
common sites for PEG attachment using hydroxyl- or aldehyde-
functionalized PEG. First-generation methods relied on
activated hydroxyl groups on end-functionalized PEGs.18,19 A
widely used method in current use involves N-hydroxysucci-
nimide (NHS) esters, which are highly reactive toward amines
at physiological pH (Figure 1a).20 Potential hydrolysis of the
ester bond of succinylated PEG can be avoided by use of a
linking carbonate group.1,21,22 NHS-terminated PEG was used
to prepare alternating multiblock copolymers of PEG and
coiled-coil peptides using NHS−PEG3.4k−NHS.23
Other methods to activate the reaction of PEG and amines
have been reviewed.1 Rather than preparing polymers with
reactive end groups, in situ activation using carbodiimides is
possible,24 and this has been used to couple the carboxylic
group of succinylated PEG to various peptides.1 Aldehyde-
terminated polymers may be reacted with N-terminal amines
(Figure 1b).1,25−27 In one example, poly(oligo-(ethylene
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glycol) methacrylate) (POEGMA) or PEG was coupled to the
3432 Da peptide hormone salmon calcitonin.28 POEGMA
contains oligomeric ethylene oxide side chains and has some
distinct properties to linear PEG while retaining advantages
such as biocompatibility. For instance, copolymerization of
diﬀerent oligo-ethylene gycol acrylates leads to the formation of
thermosensitive polymers with lower critical solution temper-
ature (LCST) behavior.29 In the conjugates of PEG or
POEGMA with salmon calcitonin, the bioactivity was not
inﬂuenced by the Mn of POEGMA (containing PEG1.1k) in
the range 6.5−109 kDa.30 Later, this group used dibromoma-
leimides for site-speciﬁc linkage to the disulﬁde bridge in
salmon calcitonin.31 The same model peptide was also
conjugated to poly((monomethoxy ethylene glycol) (meth)-
acrylates) via the disulﬁde using water-soluble organic
phosphines as catalysts.32 An amine-terminated polymer may
be attached to an aldehyde-functionalized resin, from which
peptide synthesis is performed.33
Cysteines are an attractive target for conjugation of polymers
to proteins because only a few are typically available to react
with;1 however, further discussion of protein conjugation is
outside the scope of this review. A number of thiol-reactive
groups can be used to couple end-functionalized polymers to
cysteine-terminated peptides (Figure 1c,d). One widely used
chemistry employs maleimides, which react selectively with the
thiols of cysteine residues by Michael addition in the pH range
6.5−7.5 (Figure 1c).15 To prepare atom-transfer radical
polymerization (ATRP) initiators containing maleimides,
protection is required.1 Amine-terminated PEG has been
converted to a maleimide by reaction with maleic anhydride.34
Maleimide−PEGs have been coupled to cysteine ﬂanked silk-
like peptide (EG)3EG.
35 In another case, maleimide polymers
including POEGMA were coupled to the model thiol-
containing peptide reduced glutathione (γ-ECG) as well as
the protein bovine serum albumin.36 The maleimide was
incorporated into an initiator for ATRP to produce α-
functionalized polymers. Maleimide-modiﬁed RAFT chain-
transfer agents (CTAs) have also been used to synthesize
poly(ethylene glycol) methyl ether acrylate (PEGA) for
conjugation to proteins such as lysozyme.37,38
Another chemistry that can be used to link polymers to
cysteine residues employs vinyl sulfone-terminated polymers
(Figure 1d); for example, this approach has been used to
couple PEGA to proteins.39 A PEGA−PS−PEGA triblock
copolymer with pyridyl sulﬁde end groups, prepared by RAFT
using a novel CTA, has been linked to glutathione as a model
tripeptide. The triblock forms micelles, and the conjugate forms
peptide-decorated micelles.40
Thiol-ene chemistry may also be employed to link alkene-
terminated polymers and cysteine-containing peptides. For
Figure 1. Representative coupling chemistries (adapted from ref. 17). In general, R denotes a peptide chain, and R′, a PEG chain, although in some
cases these are interchangeable (e.g., reaction e). (a) Reaction of an amine with an NHS ester forms an amide bond, (b) reaction of an amine with an
aldehyde produces a Schiﬀ base that can be reduced by borohydrides to produce a secondary amine linkage, (c) reaction of a thiol (in a cysteine
residue) with a maleimide derivative produces a thioether bond, (d) reaction of a thiol-containing peptide with a vinylsulfone-modiﬁed PEG
produces a thioether bond, and (e) Cu-catalyzed alkyne−azide click reaction produces a triazole. Adapted with permission from ref 17. Copyright
2008 Elsevier.
Figure 2. Coupling of PEG via diazonium linkage to Tyr22 in salmon calcitonin (sCT).42 Reproduced from ref 42. Copyright 2012 American
Chemical Society.
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instance, copolymers of di(ethylene glycol) methyl ether
methacrylate (DEGMEMA) and allyl methacrylate have been
linked to α-keratin using this chemistry.41
Diazonium derivatives may be coupled to tyrosine, and this
has been exploited to link a diazo-functional PEG (PEG6) to
the pentapeptide (D-Ala2)-leucine enkephalin (an endogenous
opioid peptide) as well as diazo-functional PEG6 and PEG45 to
salmon calcitonin (Figure 2).42 This method was also employed
using POEGMA instead of PEG.
Carboxylated PEG may be linked to oligopeptides via NHS
activation with N,N′-dicyclohexylcarbodiimide (DCC).43 This
method was used to prepare conjugates of short PEG chains
(PEG350−750) with hydrophobic tetra- and hexapeptides. The
conjugates formed micelles with thermosensitive properties
because of the LCST behavior.
Oxime formation by reaction of aminooxy end-functionalized
polymers and levulinyl-modiﬁed proteins or peptides may also
be used to prepare conjugates, such as those containing
POEGMA.44 The method has also been used to conjugate
branched PEG-based polymers to peptides (small proteins)
such as an anti-HIV protein45,46 (Figure 3) or synthetic
erythropoietic proteins.47
On-resin coupling of PEG−CH2−COOH to N-terminal
peptide resins has been carried out via acylation, occurring
rapidly and with high conversion in the case of lower molar
mass PEG (750 g mol−1) but not for PEG10k (PEG5k could be
coupled to unhindered N-terminal Gly but not hindered Ile).48
Di-PEGylation was also possible using C-terminal PEGylated
amino acids (ornithine or lysine), and this method was used to
prepare di-PEGylated interleukin-2 peptide fragments. Lysine
side chain/C-terminal PEG conjugates were also prepared. The
authors also showed that PEG end-functionalized with
methylnorleucine (Nle) is a good reagent for N-terminal
PEGylation using BOP activation.49,50 The method was used to
prepare a number of PEG−OCHH2CO−Nle(NANP)3 con-
jugates with PEG500049 as well as a conjugate of PEG5000 and
a 13-residue peptide fragment of interleukin-2.50
A mixed grafted PLL poly(L-lysine) conjugate was prepared
by coupling PEG2k with an NHS end group via the lysine
amine as a side chain.51 In addition, a fraction of PEG chains
were functionalized with RGD-based peptides via vinylsulfone
groups coupled to cysteine residues. The incorporation of the
RGD cell adhesion motif supported the growth of human
dermal ﬁbroblasts while blocking adsorption of serum proteins.
In a related context, PEG5000 has been grafted via a lysine
residue in ﬂuorophore-labeled RGD peptides for applications in
bioimaging.52 PEGylation was found to enhance ﬂuorescence
quantum yield while reducing interactions between ﬂuoro-
phores and biomolecules in cells.
2.1.2. Click Coupling. The well-known [3 + 2] cycloaddition
click reaction (Figure 1e) between alkynes and azides has been
widely used in the synthesis of bioconjugates.53
By using click reactions, grafting eﬃciencies approaching
100% are possible, as demonstrated with poly(γ-propargyl-L-
glutamate), to which azide-terminated PEG with molar masses
in the range 750−5000 g mol−1 has been attached (Figure 4).54
The conjugates adopt a α-helical secondary structure. Alkyne−
azide click chemistry was used to link PEGA to a GGRGDG
peptide.55
Peptidomimetics have also been linked via click ligation to
PEG, for example, using alkyne-functionalized peptidomimetics
and α,ω-diazido-PEG.56 Other examples of click reactions are
provided in the following sections.
2.1.3. Noncovalent Coupling. Reversible coupling can be
achieved using noncovalent chemistries. For example proteins
(or peptides) may be tagged with the commonly used (in
aﬃnity chromatography) hexahistidine motif, which is recog-
nized by the complementary nickel−nitriloacetic acid (Ni-
NTA) complex on end-modiﬁed PEG.57 This has been
proposed as a facile, reversible PEGylation method for the
screening of therapeutic proteins in vivo.
The interaction between heparin and a heparin-binding
growth factor (VEGF) has been used to prepare noncovalent
hydrogels of heparin-terminated four-arm PEG and VEGF.58
The presence of VEGF receptors on endothelial cells lead to
erosion of the hydrogels, producing a biomaterial responsive to
a speciﬁc receptor cue.
The biotin−streptavidin complex has been used to couple
polymers and proteins noncovalently;1 however, we are not
aware of the use of this high-binding-aﬃnity system to prepare
PEG−peptide conjugates.
2.2. Peptide Synthesis from PEG Chains (“Grafting
to”). N-Carboxyanhydride (NCA) polymerization from PEG
macroinitiators enables the synthesis of a range of polymer−
peptide conjugates.59,60 NCA of homopolypeptides such as
poly(L-proline) as well as copolymers from PEG macro-
initiators has been demonstrated, and self-assembly in the solid
state was noted.61 The polyproline II secondary structure was
adopted in water. NCA polymerization has also been used to
polymerize L-alanine from amino-terminated PEG.62 It has also
been used to prepare PEG-poly(Z-L-lysine) diblocks with
Figure 3. Coupling of aldehyde-functionalized PEG to an
isopropylidene-functionalized 34-residue anti-HIV peptide at lysine
45 via oxime exchange using methoxylamine.46 Reproduced from ref
46. Copyright 2005 American Chemical Society.
Figure 4. Clicking of PEG to poly(γ-propargyl-L-glutamate).54
Reproduced with permission from ref 54. Copyright 2009 WILEY-
VCH Verlag GmbH & Co. KGaA. http://onlinelibrary.wiley.com/doi/
10.1002/anie.200904070/abstract.
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dodecylamine or α-naphthylamine (as a ﬂuorophore) between
the two blocks.63
A variety of chemistries have been employed using PEG as a
cleavable support for peptide synthesis (prior to cleavage,
PEG−peptide conjugates are produced).64 PEGylated resins
are available commercially (see below). The PEG chain is
connected to the peptide via a linker, of which examples include
those that are photocleavable, acid- or base-labile, or thiol-
labile. A method to prepare 9-ﬂuorenylmethyl chloroformate
(Fmoc)−PEG amino acids to incorporate PEG spacers within
peptides, compatible with solid-phase synthesis methods, has
been employed by several groups using PEG−amino acids with
3−8 spacers.65−67 This builds on earlier work in which shorter
ethylene glycol spacers were incorporated into disulﬁde-bridged
peptides.68
A method to convert synthesized PEG (up to EG29) diols
into Fmoc−amino acids compatible with solid-phase peptide
synthesis has been reported.69 These were used to synthesize
(on resin) a peptide−PEG17−folate conjugate incorporating a
folic acid cysteine-targeting ligand as well as an N-terminal
amphipathic peptide with high transfection eﬃciency. The
peptide−PEG17 conjugate was coupled to the cysteine-folate
ligand using maleimide coupling chemistry. Monodisperse
Fmoc−PEG−COOH with a range of PEG (PEG2−PEG36) are
now available commercially (from Quanta Biodesign)17 and
have been used to prepare PEG−peptide conjugates such as
PEG−FFKLVFF−COOH.70
PEG-functionalized resins are commercially available under
the trade name Tentagel PAP (from Rapp Polymere).71−73
These comprise cross-linked polystyrene beads to which PEG
chains are preattached with a labile benzyl ether linkages. A
range of PEG molar mass beads is available. The method was
originally developed to attach PEG to improve the solubility of
hydrophobic peptides or lipopeptides,71 although recent
attention has focused on the interesting self-assembly proper-
ties arising from the amphiphilicity of PEG−peptide conjugates.
Mutter et al. developed liquid-phase synthesis of peptides up
to 20 residues from linear PEG (5−20k) supports,74 although
the method has yet to ﬁnd widespread application.75 These
authors prepared PEG with several acid- and photocleavable
linkers for the synthesis of a series of test peptides.
PEG chains have been used as supports for liquid-phase
peptide synthesis, as reviewed in detail elsewhere.64 In general,
the synthesis has been carried out in organic solvents, although
some examples in water have been reported (using 1-ethyl-3-
(3-(dimethylamino)propyl)carbodiimide (EDC) instead of
DCC). Figure 5 shows a direct esteriﬁcation method to
produce, in this case, a bifunctional conjugate. This method has
been used with PEG up to PEG20k and for up to 14-residue
peptides.76 Fragments of the peptide secretin have been
synthesized on a PEG10k support, which provides a solubilizing
protecting group.77−79 The stepwise synthesis of a fragment of
insulin B was performed using a PEG3k support.80 Liquid-
phase methods were used to prepare PEG−peptides incorpo-
rating PEG10k and oligo-glycine peptides with 1−9 glycine
repeats (β-sheet structures were observed for conjugates with
longer glycine sequences at low dilution in chlorinated
solvents).81 Similarly, t-Boc-Xn-G-PEG conjugates were pre-
pared with X = Ala, n = 1−8 or X = Val, n = 1−6.82
2.3. Polymer Synthesis from Peptide (“Grafting
from”). In the grafting from method, initiators for polymer-
ization methods such as ATRP may be incorporated at the
peptide termini. This method has been widely used to prepare
protein−polymer conjugates,83 although this is outside the
scope of the present review. The technique has also been used
for polymer−peptide conjugates.84 In one example, two
diﬀerent ATRP initiators were attached at the termini of a
model matrix metalloprotease (MMP) substrate 11-residue
peptide, and POEGMA was polymerized from the C terminus
and poly(N-isopropylacrylamide) (PNIPAM) was polymerized
from the N terminus.85 This conjugate self-assembled into
micelles under suitable conditions in aqueous solution, and
enzymatic degradation of the peptide linker was demonstrated.
A reversible addition−fragmentation transfer (RAFT) agent
has been appended to a solid-phase-synthesized peptide and
used as a macroinitiator for RAFT and also via functionality
shift for ATRP, which may be used to polymerize PEG
(although this study involved polymerization of n-butyl
acrylate).86
2.4. Synthesis of PEG Side-Chain Polymer−Peptide
Conjugates. As an alternative to the attachment of linear PEG
to peptides, it is often synthetically convenient to use PEG-rich
polymers bearing PEG or oligo-ethylene glycol side chains such
as acrylates or methacrylates, which are conveniently prepared
by living radical polymerization methods such as RAFT (and
ATRP, although this is also used directly to synthesize PEG).16
Polymers with PEG “grafts” enable the incorporation of PEG of
a deﬁned length at a controlled density along the polymer
backbone. Furthermore, certain PEG acrylates show very well-
deﬁned LCST behavior (i.e., they undergo a sharp coil−globule
transition on heating). Incorporation of PEG in the monomer
(“grafting through”) is generally advantageous compared to
grafting to, where quantitative functionalization can be hard to
achieve.
Short PEG chains have been grafted to PBLG,87 and PEG
chains with Mw = 1k, 2k, and 3k have been grafted to poly(L-
lysine),88 with both showing moderate grafting densities.
Poly(L-glutamates) with oligo-ethylene glycol (1, 2, or 3
repeats) have been prepared by NCA polymerization of
ethylene glycol-modiﬁed amino acid monomers.89 The
PEGylated polymers exhibit LCST behavior in water. The
LCST transition can be tuned via the composition (PEGylated
monomer content) of the copolymer or the enantiomeric
composition.89 Cysteine-based C and CF peptides have been
attached to polybutadiene chains in a PEO−polybutadiene
diblock via free-radical addition.90 Spherical or worm-like
micelles or vesicles were observed depending on the hydro-
phobicity of the conjugate copolymers.
Langer’s group studied polyhistidine polymers with PEG
grafts (PEG5k) for gene delivery (plasmid DNA) and
Figure 5. Direct esteriﬁcation of PEG with amino acids using
dicyclohexylcarbodiimide (DCC).64 Reproduced from ref 64. Copy-
right 1997 American Chemical Society.
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compared these conjugates to linear PEG−polyhistidine
diblocks.91 Steric hindrance because of PEG led to a direct
relationship between PEG content and the size of the
complexes formed. The transfection eﬃciency was good, and
cytotoxicity to macrophages was low.
2.5. Synthesis of Tethered PEG peptides. PEGylated
peptides may be tethered to solid supports, for instance, to
create functionalized surfaces for cells. Ulijn’s group developed
a system comprising amine-terminated PEG tethered to silica
surfaces in which initially blocked cell adhesion peptide motifs
were subsequently exposed via enzymatic cleavage of the
terminal blocking group.92,93 In a ﬁrst example, PEGA-coated
surfaces were created with reactive amine groups for the
sequential coupling with Fmoc−amino acids to produce
PEGA−DGRF−Fmoc. Because proteases such as α-chymo-
trypsin cleave on the carboxylic side of phenylalanine residues,
they can be used to remove the blocking Fmoc unit, as was
demonstrated, leading to the spreading of osteoblast cells.92 In
a second example, Fmoc−amino acids were then coupled to the
PEG−amine to produce PEG−DGRAAFmoc.93 The Fmoc unit
serves as a blocking group that can be removed by enzymatic
cleavage at the alanine residues using elastase, thus exposing the
cell adhesion RGD motifs. PEG/RGD-based peptide con-
jugates grafted to solid substrates have been studied as supports
for cell growth and diﬀerentiation.51,93
3. SELF-ASSEMBLY OF β-SHEET PEPTIDE−PEG
CONJUGATES
Lynn and co-workers investigated the ﬁbrillization of
conjugates of PEG with amyloid β (Aβ) peptide fragments
(Figure 6).94 Speciﬁcally, they studied the self-assembly of
Aβ(10−35)−PEG3k. In contrast to the Aβ(10−35) peptide
itself, conjugation to PEG was found to enhance the solubility
and led to concentration-dependent reversible ﬁbrillization.
The ﬁbril dimensions (of the peptide core and PEG corona)
were determined via contrast matching small-angle neutron
scattering (SANS) experiments,95 and the pH dependence of
these parameters was also examined.96
Conjugates comprising an N-terminal alkyl chain attached to
the amyloid-forming hexapeptide KTVIIE and C-terminal
PEG3000 were observed to form ﬁbrils. These could be
disassembled by removal of the alkyl chains via a UV-active
photolabile nitrobenzyl group.97
A diblock conjugate incorporating the peptide
QQKFQFQFEQQ and a PEG3.7k block self-assembles into
β-sheet ﬁbrils.98 The peptide is designed as a transglutaminase
substrate for enzymatic biofunctionalization of the supra-
molecular structure. A diblock conjugate containing PEG440
and the truncated peptide KFQFQFQ also formed ﬁbrils (the
corresponding peptide−PEG−peptide conjugate was not
soluble in water), although the analogous peptide-terminated
triblock did not (because of insolubility in aqueous solution).
The morphology of ﬁbrils formed by the PEG conjugates
diﬀered from those of the parent peptides.98
PEGylation can hinder β-sheet formation. This is exempliﬁed
by a study on a designed alanine-rich peptide.99 The peptide
self-assembles into helices under ambient conditions at acidic
pH but converts into β-sheets at high temperature. PEGylated
peptides (conjugated to PEG5k or PEG10k) show similar
behavior; however, β-sheet formation at elevated temperature is
slowed, and there is reduced cooperativity in the thermally
induced unfolding.99
Nematic and hexagonal columnar-phase formation in
aqueous solution by the peptide−PEG conjugate FFKLVFF−
PEG3k was also noted.73,100,101 The peptide is based on a
fragment of the amyloid β peptide, KLVFF, Aβ(16−20)
extended at the N terminus by two phenylalanine residues. This
peptide amphiphile forms core−shell cylindrical ﬁbrils. The
PEG coronas around the peptide ﬁbrils are expected to mediate
the purely repulsive interactions because attractive interactions
can result from interpenetration of coronal chains. It is
interesting to consider how the balance of electrostatic and
steric (soft elasticity from polymer corona) interactions
inﬂuence the packing constraints that lead to the nematic and
hexagonal columnar phases observed in these PEG−peptide
conjugates. Nematic ordering has also been reported for a
Figure 6. TEM image of ﬁbrils formed by Aβ(10−35)−PEG3000.94
The scale bar is 200 nm. Reproduced from ref 94. Copyright 1998
American Chemical Society.
Figure 7. (a, b) Schemes for the packing of FFKLVFF β-strands based on X-ray diﬀraction for (EG)n−FFKLVFF−COOH with (a) n = 5 and 11 and
(b) n = 27. (c) Scheme for self-assembled structure based on stacking of β-sheets shown in panels a and b.70 Reproduced with permission from ref
70. Copyright 2012 The Royal Society of Chemistry. http://pubs.rsc.org/en/content/articlehtml/2012/sm/c2sm25546d.
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PEG−peptide amphiphile containing a two-tailed peptide motif
attached to a rigid aromatic branch point.102 This forms tape-
like aggregates that show nematic ordering at higher
concentration.
The eﬀect of PEG molar mass on the self-assembly of
FFKLVFF−PEG with PEG1k and PEG2k (both C-terminal
PEG) as well as PEG10k−FFKLVFF (N-terminal PEG) was
also investigated.103 The three FFKLVFF−PEG hybrids form
ﬁbrils comprising a FFKLVFF core and a PEG corona. The β-
sheet secondary structure of the peptide is retained in the
FFKLVFF ﬁbril core. At suﬃciently high concentration,
FFKLVFF−PEG1k and FFKLVFF−PEG2k form a nematic
phase, whereas PEG10k−FFKLVFF exhibits a hexagonal
columnar phase. Simultaneous small-angle neutron scattering/
shear ﬂow experiments were performed to study the shear ﬂow
alignment of the nematic and hexagonal liquid crystal phases.
On drying, PEG crystallization occurs without disruption of the
FFKLVFF β-sheet structure, leading to characteristic peaks in
the X-ray diﬀraction pattern and FTIR spectra (also see Section
7). The stability of β-sheet structures was also studied in blends
of the FFKLVFF−PEG conjugates with poly(acrylic acid)
(PAA), which can hydrogen bond to PEG, potentially
modifying self-assembly. Although PEG crystallization was
observed only up to 25% PAA content in the blends, the
FFKLVFF β-sheet structure is retained up to 75% PAA.
The inﬂuence of the PEG chain length on the self-assembly
of N-terminal PEGylated FFKLVFF−PEG conjugates has been
examined.70 Three (EG)n−FFKLVFF−COOH conjugates were
studied, where EG denotes ethylene glycol and n = 5, 11, or 27
is the PEG degree of polymerization. Importantly, these
samples are based on commercially available (Quanta biode-
sign) monodisperse ethylene glycol oligomers. For these model
conjugates, where PEG polydispersity eﬀects are eliminated, X-
ray diﬀraction revealed diﬀerent packing motifs dependent on
PEG chain length (Figure 7). This is correlated to remarkable
diﬀerences in self-assembled nanostructures depending on PEG
chain length. The control of strand registry points to a subtle
interplay between aromatic stacking and electrostatic and
amphiphilic interactions.
The inﬂuence of PEG molar mass on the self-assembly of
FFFF−PEG has been examined. Nanotubes were observed for
a conjugate with a low PEG molar mass (350 g mol−1),104
whereas at higher PEG molar mass (studied in the range 1.2−
5k), ﬁbrils are observed.104,105 The nanotubes comprise
antiparallel β-sheets that are stabilized by π−π stacking of the
aromatic residues.106 Soft hydrogels arising from nanotube
entanglements are reported at higher concentration.106
The self-assembly into β-sheet ﬁbrils of the conjugate
DGRFFF−PEG containing the RGD cell adhesion motif
(attached N terminally), three F residues to ensure
amphiphilicity, and PEG3k in aqueous solution has been
observed.107 The adhesion, viability, and proliferation of human
corneal ﬁbroblasts were examined for ﬁlms of the conjugate on
tissue culture plates (TCP) as well as low-attachment plates.
On TCP, DGRFFF−PEG3k ﬁlms prepared at suﬃciently low
concentration are viable, and cell proliferation was observed.
However, on low-attachment surfaces, neither cell adhesion nor
proliferation was observed, indicating that the RGD motif was
not available to enhance cell adhesion. This was ascribed to the
core−shell architecture of the self-assembled ﬁbrils with a
peptide core surrounded by a PEG shell, which hinders access
to the RGD unit.
Tape structures were observed for a PEG−peptide
containing PEO68 and a peptide incorporating a (TV)4−
ester−VG “switch” peptide sequence that forms β-sheet tape
structures upon increasing the pH to 6.2 in aqueous solution
because of an O → N acyl switch.108 The authors observed
ﬁbrils for a related conjugate comprising PEG linked via a
dibenzofuran-based linker to two tails containing the VTVT
peptide.109 It was pointed out that short peptide end groups
can be used to direct the ordering of PEO into ﬁbrillar
structures.
4. SELF-ASSEMBLY OF COILED-COIL AND α-HELICAL
PEPTIDE−PEG CONJUGATES
Klok and co-workers have observed that the coiled-coil
structure of designed peptides can be retained upon
conjugation to PEG.110 The peptides are based on a de novo
sequence designed by Hodges et al.111 and incorporate two
heptad LAEIEAK sequences conjugated to PEG with n = 15 or
40. An equilibrium between unimers and dimeric and
tetrameric coiled-coil aggregates was proposed, with increases
in concentration or temperature favoring the more aggregated
state (Figure 8).110 The close folding of PEG around the
coiled-coil structures was indicated by electron paramagnetic
resonance (EPR), which also pointed to a parallel alignment of
the helices, as least for the dimeric species.112
A later study focused on the secondary structure in a related
series of coiled-coil peptides with substitutions among the
charged residues, which compared PEG conjugates (PEGn, n =
Figure 8. Proposed model for the self-assembly of PEG−peptide conjugates containing the coiled-coil peptide GEAK(LAEIEAK)2−LAEIY−Am.
110
Reproduced from ref 110. Copyright 2003 American Chemical Society.
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15 and 40) and the parent peptides.113 The stability of the
secondary structure against changes in concentration and pH
was analyzed. Substitutions of E and K residues did not
inﬂuence the ability of the peptides and conjugates to form
coiled-coil structures. The biocompatibility of the conjugates
was also examined via hemolysis assays. The stability of
PEGylated conjugates (compared to the parent peptide) based
on this type of coiled-coil peptide against changes in pH and
concentration was studied via CD spectroscopy.114 In addition,
several switch peptides,115 which are designed to switch
between α-helical and β-sheet structure depending on pH,
were investigated in comparison with their PEG conjugates.114
The conjugates of the coiled-coil peptides exhibited reduced
concentration-dependent changes in α-helix content, although
the coiled-coil structure was retained. The switch peptide-PEG
conjugates exhibited enhanced stability of the coiled-coil
structure against pH increase. Solid-state structures were also
examined by TEM and AFM.
The formation of heterodimers between pairs of E- and R-
rich coiled-coil peptides was not impaired by their incorpo-
ration into alternating multiblock PEG copolymers.23
The inﬂuence of PEG2k on the secondary structure of a
series of peptides (VSSLESK)n with n = 3−6 was examined
using CD spectroscopy.116 The conjugates with longer peptides
n = 5 and 6 adopted a two-stranded α-helical structure in
aqueous solution. PEG was found not to interfere with the
formation of α-helices for the shorter conjugates as well. The
thermal stability of the conjugate with n = 6 was higher than
that of the corresponding peptide.
The conformation of the PEG chain attached laterally to
coiled-coil 3- or 4-helix bundle peptides (30-mers) via cysteine
residues using maleimide-functionalized PEG was examined by
SANS.117 The form factor was described by a cylinder (for the
coiled-coil structure) and a Gaussian coil for the PEG
conformation.
Complexation of PEG−K and PS−E containing α-helical
peptides termed E (G(EIAALEK)3) and K ((KIAALKE)3G)
with opposite charges led to the formation of heterocoiled coils
and thus a noncovalently linked PS−E/K−PEG triblock
(Figure 9), which self-assembles into rod-like micelles.118 In
related work, the coiled-coil conjugate K−PEG77 was prepared
as part of a study on complexation with diblocks containing
oppositely charged coiled-coil sequences (EIAALEK)3 and
PBLG.119 Vesicle formation was observed in the case of
complexes formed with lower molar mass (PBLG36) diblocks.
Oligo-ethylene glycol (EG2) has been attached to a protein
with a grafted minimal p53 tumor suppressor peptide sequence
to improve the solubility of the α-helix-stabilized self-assembled
peptide nanostructure.120
5. SELF-ASSEMBLY OF PEPTIDE−PEG−PEPTIDE,
PEG−PEPTIDE−PEG, AND RELATED CONJUGATES
Telechelic peptide−PEG−peptide conjugates containing hy-
drophobic peptides oﬀer the possibility to create hydrogels by
physical association of the terminal peptide domains. This has
been further enhanced with disulﬁde cross-linking (Figure 10)
of conjugates based on terminal peptides incorporating
designed six-heptad leucine zipper coil motifs.121 The
unstructured midblock comprises ((AG3)PEG)10. Intermolec-
ular interactions between these triblock constructs was later
probed by AFM force measurements under extension/
retraction, and the adhesive interactions between molecules
were found to increase upon lowering the pH.122 The inﬂuence
of the end blocks on the erosion rate of this type of leucine
zipper peptide hydrogel was examined.123 Erosion was much
slower for hydrogels constructed from triblocks with dissimilar
end blocks compared to those with the same end groups, an
eﬀect ascribed to reduced chain looping in the heterotelechelic
constructs.123 Similar constructs were later developed to create
cell adhesive materials by incorporation of the RGDS cell
adhesion motif or heparin-binding motifs into the terminal
coiled-coil peptide domains.124 Furthermore, cross-linked
coatings could be produced by 1-ethyl-3-(3-(dimethylamino)-
propyl) carbodiimide (EDC)-mediated cross-linking of prox-
imal Glu and Lys residues.
A triblock comprising PEG end blocks and a central peptide
block of silk-like tandem (AG)3EG repeats forms ﬁbrils in
aqueous solution irrespective of PEG with a molar mass in the
range 750−5000 g mol−1 is used.35
In another example, collagen-mimetic peptides were attached
to four-arm PEG. Hydrogels were formed via physical cross-
links mediated by thermally reversible triple helical assembly of
collagen-mimetic peptides.125 Hydrogel formation by a
peptide−PEG−peptide conjugate containing peptides derived
from the coiled-coil region of ﬁbrin has been investigated.126
The hydrogels may have application in tissue engineering and/
or wound healing.
A thermoplastic hydrogel has been produced from a
hexablock copolymer containing PEO and PBLG, with a
complex architecture comprising four PBLG-bearing arms, two
of which also contain PEO.127 The thermoplastic properties
may be due to microphase separation within the concentrated
hydrogels.
The self-assembly in aqueous solution of peptide−PEG−
peptide conjugates comprising aromatic dipeptides linked
telechelically to PEG1.5k has been examined.128 The role of
capping Fmoc (N-ﬂuorenyl-9-methoxycarbonyl) units at one or
both termini was also examined. A self-assembled β-sheet ﬁbril-
based hydrogel was identiﬁed for a conjugate containing
dityrosine end groups (and a C-terminal Fmoc unit), which
exhibits a gel−sol transition near body temperature (Figure
11).128 This thermoresponsive PEG-based biofunctional hydro-
gel is expected to have diverse potential uses in delivery or
diagnostics for biomedical applications. Another group later
prepared similar telechelic conjugates of desaminotyrosine or
desaminotyrosyl-tyrosine with a linear PEG3k midblock and
Figure 9. Heterocoiled-coil formation between glutamic acid and
lysine-containing helical peptides attached to polystyrene and PEG
chains leads to the formation of a noncovalent ABC triblock
copolymer.118 Reproduced from ref 118. Copyright 2008 American
Chemical Society.
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also four-armed−PEG conjugate. A critical aggregation
concentration was noted for the linear midblock conjugate,
pointing toward self-assembly at high concentration.129
As mentioned in Section 2.2, Fmoc−PEG amino acids have
been developed that incorporate oligo-ethylene glycol spacers.
Boumrah et al. developed the synthesis of these residues,
consistent with solid-phase peptide synthesis methods, and
incorporated triethylene glycol repeats into their disulﬁde-
bridged atrial natriuretic factor peptide analogues.68 A tyrosine
kinase-based tetrapeptide has been incorporated within
pYTGL−(ethylene glycol)n−pYETL conjugates (pY, phos-
phorylated tyrosine) with n = 4 or 6.67 The spacer leads to
an aﬃnity between the two linked phosphopeptides that is
comparable to that between the two sequences in the full native
peptide, showing that the PEG spacer can substitute for the
intervening amino acids. PEG spacers have been incorporated
into multivalent (four-arm dendron) peptide constructs with
peripheral cyclo(RGDfE) integrin-targeting units attached via
hexaethylene glycol spacers linked to terminal lysine units.65
Peptides incorporating PEG spacers have been developed for
applications in gene delivery. A DNA-binding lysine sequence
(K16) was separated from a disulﬁde-bridged integrin-binding
sequence (CRRETAWAC) by oligo-ethylene glycol spacers
with 3−8 repeats.66 The PEG spacer delivered enhanced
stability in buﬀer compared to control (peptide lacking PEG
spacer).
A L4K8L4VPRGS−PEO conjugate containing a VPRGS
substrate for thrombin self-assembles into β-sheet ﬁbrils in
response to addition of the enzyme (in contrast to a peptide
containing a scrambled peptide sequence).130 Heterotelechelic
conjugate PS−L4−PEO (PS, polystyrene), a so-called peptide-
inserted triblock copolymer with a tetraleucine β-sheet-forming
midblock, forms vesicles in aqueous solution.131 This peptide
was prepared starting from a Tentagel PAP PEGylated resin
(Section 2.2). ATRP of PS was then performed from a
brominated L4−PEG macroinitiator.
The solid-state morphology of a silk-based multiblock ABCD
copolymer where A, GAGA; B, EO5; C, AGAG; and D, EO13
has been investigated (P1, Figure 12).132 In these copolymers,
PEG replaces the amorphous domains within the native silk
structure (Figure 12a). Microphase separation was noted with
20−50 nm peptide domains within a continuous PEO matrix.
In later work, the solid-state structure of ABCD multiblocks
containing the Bombyx mori (silk worm) sequence GAGA was
compared to that of multiblocks containing the Nephila clavipes
spider silk-type sequence AAAAAA (P2 and P3, Figure 12).
The formation of antiparallel β-sheets was observed in both
cases. The copolymers containing the oligo-alanine sequence
exhibited a higher modulus than those of the GAGA
copolymers, and this was ascribed to the presence of physical
cross-links.133
Figure 10. Proposed structure of gels formed by a peptide−PEG−peptide conjugate containing α-helix end blocks and C-terminal cysteine
residues.121 The hydrogel breaks down upon increasing pH or temperature. Reprinted with permission from ref 121. Copyright 1998 AAAS. http://
www.sciencemag.org/content/281/5375/389.full.html.
Figure 11. Temperature dependence of molar ellipticity at 217 nm
(measuring β-sheet content) of an aqueous solution (1.3 wt %) of
conjugate NH2−YY−PEG35−YY−Fmoc.128 There is a large decrease
in β-sheet content centered around 37 °C. Reproduced with
permission from ref 128. Copyright 2011 WILEY-VCH Verlag
GmbH & Co. KGaA. http://onlinelibrary.wiley.com/doi/10.1002/
mabi.201100022/abstract.
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6. SELF-ASSEMBLY OF PEG−PEPTIDE CONJUGATES
CONTAINING SYNTHETIC HOMOPOLYPEPTIDES
6.1. Self-Assembly in the Solid State. In the solid state,
PBLG−PEG conjugates undergo microphase separation of the
components of the block copolymers. This leads to hierarchical
ordering because of the additional shorter length scale
periodicities resulting from the packing of the PBLG, its
secondary structure, and the crystal structure of PEG (if the
molar mass is suﬃciently large). Floudas et al. reported that the
phase behavior of PBLG−PEG−PBLG triblocks depends on
the composition, speciﬁed as the peptide volume fraction, f.134
For copolymers with low peptide volume fractions ( f < 0.4),
microphase separation was noted along with α-helical or β-
sheet ordering of PBLG (depending on chain length) and
chain-folding of crystalline PEG.134 In contrast, for f > 0.4, no
regular microphase-separated structures were noted, and only
an α-helical secondary structure of PBLG was observed. Our
group subsequently examined the microphase-separated
morphology within the same series of triblock copolymers via
SAXS, AFM, and TEM experiments.135 A phase diagram was
presented, including ordered structures that were observed for
some samples with f > 0.4. The PBLG adopts a mixture of α-
helical and β-sheet structure for low chain lengths (n < 18), but
it is purely α-helical when the degree of polymerization is
larger.
Microphase separation into a lamellar structure was observed
in the solid state (solvent cast samples) for a series of PBLG−
PEO-PBLG triblocks containing 25−75% PBLG.136 The
WAXS pattern was dominated by the contribution from the
α-helical PBLG. This group also observed microphase
separation in the ﬁlms cast from a PCLL−PEO−PCLL
(PCLL, poly(ε-benzyloxycarbonyl-L-lysine)) triblock.137 Lamel-
lar ordering has been reported in the solid state of di- and
triblock copolymers of PEO and poly(DL-valine-co-DL-leu-
cine).138
Ordering in the solid state has been observed for complexes
of a PEG−PLGA (PLGA, poly(L-glutamic acid)) diblock with
n-alkylamines (octadecylamine, dodecylamine, and octyl-
amine).139 Hierarchical ordering was observed, ranging from
the length scale associated with PEG crystallization to the
PLGA−alkylamine complexes (lamellar structure for the
octadecylamine complex) as well as microphase separation of
the block copolymer (also lamellar).
The morphology and mechanical properties in the solid state
of a PBLA−PEO−PBLA (PBLA, poly(benzyl L-aspartate))
triblock have been examined.140 The PBLA chains adopted a α-
helical conformation, whereas the PEG also crystallized,
although an increase in β-sheet content of the PBLA chains
was noted upon cooling following heating above the PEO
melting temperature.
Microphase separation in the solid state was suggested as a
result of the observation of two distinct thermal transitions by
DSC for a poly(L-alanine)−PEG conjugates.62
6.2. Self-Assembly in Solution. In solution, PEG−
polyelectrolyte diblocks based on charged synthetic peptides
can self-assemble into vesicles. In one study, the kinetics of the
Figure 12. (a) Native sequence of N. clavipes major ampullate showing the alanine-rich β-sheets (highlighted) and glycine-rich amorphous regions.
(b) Generic structure of designed silk-inspired segmented multiblock copolymers P1−P3 in which the amorphous segments are replaced by ﬂexible
PEG blocks.133 Reproduced from ref 133. Copyright 2001 American Chemical Society.
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growth of PEG−poly(aspartic acid) unilamellar vesicles via 2D
supramolecular polymerization has been monitored by dynamic
light scattering.141 A four-armed H-shaped (PzLL)2−PEG−
(PzLL)2 conjugate (PzLL, poly(ε-benzyloxylcarbonyl-L-lysine))
self-assembles into vesicles in aqueous solution.142 Further-
more, the vesicles can be loaded with the hydrophobic drug
doxorobucin and delivered to human breast cancer cells.
PEG−peptide diblock copolymers can form polyion complex
micelles (PICs) by pairwise association of diblocks containing
oppositely charged blocks. In one example, PICs were observed
in aqueous solutions of PEG−poly(aspartic acid) (P(Asp)) and
PEG−poly(lysine) (P(Lys)).143 Vesicle formation by complex-
ation of a pair of diblocks containing oppositely charged blocks
has been observed.144 The vesicles, termed PICsomes, were
formed by complexation of PEG−P(Asp) (anionic) with PEG−
P(Asp-AE) or PEG−P(Asp-AP), where these cationic blocks
are prepared by aminolysis of poly(β-benyl-L-aspartate). These
vesicles were shown, by ﬂuorescence imaging, to be semi-
permeable. Triblock copolymers can self-assemble into three-
layer micelles. In one example, micelle-forming PEG−PMPA−
PLL copolymers were investigated for DNA condensation.145
The PLL forms the micelle core, with a poly(3-morpholino-
propyl) aspartamide (PMPA) buﬀering inner layer and a
biocompatible PEG outer layer. Enhanced transfection of DNA
into HeLa cells was observed for the three-layer micelles
compared to those from PEG−PLL.
A thermoresponsive conjugate of PEG and poly(γ-(2-
methoxyethoxy)esteryl-L-glutamate) has been prepared by
ring-opening polymerization.146 Extended annealing times
drive a transition in peptide secondary structure from helical
to β-sheet, leading to a concomitant nanostructure transition
from worm-like micelles to nanoribbons.
The conformational properties (α-helical structure) of PBLA
in a PEO−PBLA diblock in organic solvents has been examined
by NMR and optical rotation measurements.147
Charged polypeptide blocks within self-assembling block
copolymers can form complexes with oppositely charged
species, leading to novel nanostructures. Micelles were
observed for PEO−PLL diblocks forming complexes with
retinoic acid. The α-helix formed by PLL is stabilized over a
wider pH range within the complexes.148 This was also
observed in the solid state and is in contrast to the mixed α-
helix/β-sheet structure for the PLL block in the uncomplexed
copolymer. The micelle core contains a smectic-like PLL−
retinoic acid complex. Nanoparticles were observed upon
complexation of a PEO−PGlu (PGlu, poly(L-glutamate))
conjugate with diminazene.149 Under pH 7.4 conditions
where the PGlu adopts a random-coil structure, complexation
led to a transition to α-helical structure.
7. PEG CRYSTALLIZATION EFFECTS ON
SELF-ASSEMBLY
For PEG of suﬃciently high molar mass, crystallization is
observed in the dry state. This can inﬂuence the nanostructure
observed for PEG−peptide conjugates, for example, by TEM,
where the specimen is dried. We have found that PEG
crystallization can overwhelm peptide ﬁbrillization if the latter
is not strong. This was investigated for a series of PEG−peptide
conjugates: FFKLVFF−PEG3k, AAKLVFF−PEG3k, and
KLVFF−PEG3k. Fibrillization, as characterized in particular
by the presence of a cross-β amyloid structure as well as by the
macroscopic morphology, was disrupted for the conjugate
containing the weak ﬁbrillizer KLVFF, whereas ﬁbrils were
retained (on drying) for the conjugates containing the stronger
ﬁbrillizers AAKLVFF and FFKLVFF containing additional
hydrophobic AA or FF units.150,151 The formation of
spherulites resulting from PEG crystallization is observed for
the KLVFF conjugate but not for the other two (Figure 13).151
The ﬁbrillization strength depends on the number of
hydrophobic, particularly aromatic, residues; indeed, several
tables summarizing diﬀerent assessment methods of β-sheet
propensity show that phenylalanine particularly favors this
secondary structure.152−155 For AAKLVFF−PEG and
FFKLVFF−PEG, the alignment of peptide ﬁbrils also drives
the orientation of the attached PEG chains.150 These results
highlight the importance of the antagonistic eﬀects of PEG
crystallization and peptide ﬁbril formation in the self-assembly
of PEG−peptide conjugates.
As mentioned in Section 3, the self-assembly and bioactivity
of the peptide−polymer conjugate DGRFFF−PEG3k has been
investigated.107 At suﬃciently high concentration, self-
assembled β-sheet ﬁbrillar nanostructures were observed. The
ﬁbrils are observed despite PEG crystallization which occurs on
drying. This suggests that DGRFFF has an aggregation




An enzyme-responsive hydrogel has been prepared by Cu-
catalyzed click chemistry from four- or eight-armed PEG
capped with alkyne end groups and a bis-azido-funtionalized
protease-sensitive peptide.156 The peptide sequence D-Ala-Phe-
Lys is sensitive to plasmin and trypsin, leading to biodegradable
hydrogels.
A PEG−peptide micelle system that can be enzymatically
cleaved, leading to the release of unaggregated amyloid-based
peptides, has been reported.157 The βAβAKLVFF−PEG3k
conjugate incorporates the βAβAKLVFF peptide based on the
Figure 13. Polarized optical microscopy images showing spherulite formation for (a) KLVFF−PEG but not (b) AAKLVFF−PEG or (c) FFKLVFF−
PEG.150 Reproduced from ref 150. Copyright 2008 American Chemical Society.
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amyloid β peptide sequence Aβ(16−20) with two N-terminal
β-alanine residues. The enzyme α-chymotrypsin cleaves the
conjugate to produce βAβAKLVF and F−PEG3k (Figure
14).157 The hexapeptide does not aggregate into β-sheet
structures, in contrast to the heptapeptide βAβAKLVFF that
forms well-deﬁned β-sheet ribbons.158,159
Following a similar concept, it has been shown that PEG−
peptide micelles with a peptide substrate (GPLGVRG) for
MMP2 can be cleaved enzymatically, thus removing the PEG
coating and leaving polyaspartamide-based nanoparticles that
can form polyplexes with DNA.160 These PEG-free polyplex
micelles can be taken up by cells (with high endosomal escape)
for gene delivery applications.
9. PEG−PEPTIDES FOR DRUG DELIVERY
It is now well-established that attachment of PEG improves the
circulation time of PEGylated molecules as well as reducing
renal clearance. Extended circulation lifetimes result from
reduced recognition by the host response system (reduced
immunogenicity) and reduced enzymatic degradation. This
concept has been widely employed in the development of
therapeutic materials, a subject that will not be reviewed here;
instead, the focus will be solely on PEG−peptides used for drug
delivery applications.
A review by Torchilin provides a number of examples where
PEG−peptide micelles have been loaded with pharmaceutical
compounds for drug delivery applications.161 Kataoka and co-
workers have also reviewed PEGylated block copolymers,
including those incorporating polypeptides, in drug delivery
and other biological applications.162−165
PEG−peptide conjugates containing poly(aspartic acid)
(P(Asp)) have been employed by the Kataoka group and
others in several studies on delivery of model drugs. These
conjugates form PIC micelles that can be used to entrap drugs,
enzymes, and other molecules through electrostatic interactions
with the polyanionic peptide block. The enzyme lysozyme
(positively charged in aqueous solution) was trapped within
such micelles.166 Later, hydrophobic aromatic groups were
attached to the N-terminus of PEG−P(Asp) polymers to
enhance association between the PIC micelles and lysozyme;
this led to enhanced stability against increased NaCl
concentration.167
Encapsulation within PIC micelles can improve the solubility
of poorly soluble or hydrophobic molecules. For example, the
anticancer drug adriamycin forms complexes through inter-
actions between its amine group and the carboxyl unit of
poly(aspartic acid), leading to its incorporation within
micelles.168−170 Reduced toxicity as well as enhanced stability
in buﬀer was observed for the PIC micelles. This group later
developed cleavable PIC micelles based on PEG−SS−P(Asp-
(DET)), where the disulﬁde linker can be reduced by
glutathione in the cytoplasm and P(Asp(DET) denotes
poly(aspartic acid) modiﬁed with N-(2-aminoethyl)-2-amino-
ethyl) or reductants such as dithiothreitol (Figure 15).171 In
earlier work, the Kataoka group used disulﬁde formation to
produce PIC micelles from complexation of PEG−P(thiol-Lys)
containing thiolated lysine and PEG−P(Asp).172 The core
could be cross-linked in the presence of oxygen or dissociated
in the presence of a reductant such as DTT. Similar to
poly(aspartic acid) diblocks, conjugates of PEG with poly-
(glutamic acid) (PLGA) have been used in a study on the
delivery of the anticancer drug doxorubicin.173 Following a
similar concept, a hydrazone unit has been used as an acid-
sensitive linker to release adriamycin from PEG−p(Asp-Hyd-
ADR) conjugates (Hyd, hydrazone; ADR, adriamycin) in
endosomes or lysosomes.174 Complexation of a two-arm PEG−
PLGA−cholesterol conjugate with a platinum-containing
anticancer agent leads to the formation of metal-containing
polymersomes.175
Several groups have investigated PLL−PEG conjugates for
drug delivery, exploiting, in particular, the high cationic charge
of the PLL for condensation of (anionic) DNA. This system
oﬀers the biocompatibility of the poly(L-lysine) block as well as
the amphiphilicity of the diblock, which enables micellization.
The binding of plasmid DNA was investigated in a series of
papers on PEGylated polyplexes for gene therapy.176−178 A
series of diblocks with a ﬁxed PEG12k block was studied, and
the conformation of the PEG was found to depend on the PLL
segment length. In another example, Hua et al. used PLL−
PEG−PLL for slow-release drug delivery of encapsulated
paclitaxel.179 PLL−PEG diblock copolymers have been used
as micellar drug delivery systems for DNA, showing an
increased resistance to nucleases of plasmid DNA encapsulated
in the core because of electrostatic interaction with PLL.180
Figure 14. α-Chymotrypsin cleaves βAβAKLVFF−PEG3000 (βA
denotes β-alanine), which self-assembles into spherical micelles with a
PEG corona to produce F−PEG3000 and βAβAKLVFF, of which
neither self-assemble.157 Reproduced from ref 157. Copyright 2010
American Chemical Society.
Figure 15. Cleavable disulﬁde linked PEG−poly(Asp(DET)) conjugate forms polyion complex micelles with plasmid DNA.171 Glutathione in the
cytoplasm causes PEG release. Reproduced from ref 171. Copyright 2008 American Chemical Society.
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PLL-based PLL−PEG diblocks (containing poly(ε,N-(triiodo-
benzoy1)-L-lysine)) formed micelles that can be used as long-
lived carriers for the contrast medium used for X-ray computed
tomography.181 PEG−PLL diblocks form PIC micelles with
anionic dendrimer porphyrins, and this led to enhanced
intracellular photodynamic eﬃciency.182 Photodynamic therapy
has been proposed as a means to treat disease, such as cancer,
via light-triggered localized toxicity of sequestered nanoparticles
or compounds.
Micelle forming PEG−peptides incorporating synthetic
peptides such as PBLG or PBLA have similarly been used to
encapsulate a variety of poorly water-soluble drugs. PEG−
PBLG diblocks have been observed to self-assemble in aqueous
solution, and the core of the micelles can be loaded with the
benzodiazepine drug clonazepam.183 The release rate decreases
with increasing PBLG chain length. A PEG−PBLA diblock has
been used to solubilize indomethacin, a nonsteroidal anti-
inﬂammatory drug. The release rate was found to increase with
pH in the range 1.2−7.4.184
In another application, PEGylated prodrugs have been
prepared that incorporate insect-derived proline-rich antimicro-
bial peptides toward the development of novel antibacterial
compounds.185 The peptide prodrugs are released from the
conjugate by serum proteases.
As shown for synthetic PEG diblock copolymers, the shape
of nanostructures has a profound inﬂuence on circulation time
in vivo: extended cylindrical micelles (sometimes termed
ﬁlomicelles) have greatly extended circulation times compared
to spherical particles, although the latter are more readily taken
up by cells.186 The enhanced persistence of ﬁbrillar
nanostructures may be relevant to PEG−peptide conjugates,
which are often ﬁbrillar, although a systematic study of this
eﬀect has yet to be carried out.
10. SUMMARY AND OUTLOOK
PEGylation of peptides oﬀers advantages for biomedical
applications such as drug delivery or the development of
enzyme-responsive self-assembling biomaterials. PEG-based
hydrogels containing peptide motifs have been shown to have
excellent utility in the development of substrates for cell
culture, with their ultimate application in areas such as tissue
engineering although this is outside the scope of the present
review.
A range of coupling chemistries have been developed that
enable a rich diversity of PEG−peptides to be prepared, which
also facilitates the synthesis of PEG−peptide conjugates with
diﬀerent architectures (starblock polymers and multiblock
polymers). Grafting to PEG and grafting from reactions oﬀer
distinct capabilities. Peptides can be synthesized from PEG
macroinitiators (grafting to), for example, via NCA polymer-
ization incorporating noncanonical amino acids (PBLG, etc.),
enabling longer chain lengths to be accessed than is possible
with standard stepwise coupling peptide synthesis methods.
However, PEG-based resins are available commercially and are
compatible with Fmoc−peptide synthesis. Liquid-phase peptide
synthesis has been demonstrated but is not currently widely
used. Grafting from reactions involve transforming a protein
peptide into a macroinitiator. Currently, this approach is used
extensively to prepare protein-based macroinitiators for living
radical polymerization methods such as ATRP or RAFT, as
detailed earlier. Grafting through reactions enable the lateral
attachment of PEG chains to provide PEG-stabilized chains.
Furthermore, POEGMA-type copolymers with PEG side chains
on a methacrylate or acrylate backbone show LCST behavior,
which may be useful in the development of thermoresponsive
peptide-functionalized materials.
β-Sheet PEG−peptide conjugates generally self-assemble
into ﬁbrillar structures in solution. PEGylation of coiled coils
confers greater stability against changes in conditions (pH,
temperature, concentration) without perturbing the secondary
structure.
In the solid state, microphase separation is observed for β-
sheet-based peptides such as those containing silk-like
sequences. Lamellar and other morphologies are observed.
However, PEG crystallization can overwhelm any microphase-
separated structure if the peptide has a low β-sheet-forming
propensity.
Many aspects of PEG−peptide conjugates suggest excep-
tional potential for further research. Examples include remodel-
lable biomaterials, for example, photoresponsive hydrogels for
cell growth and diﬀerentiation or polyion complex micelles/
vesicles for drug delivery. The control of self-assembled
nanostructure and exploitation of diﬀerent modes of self-
assembly in biomedical applications (e.g., inﬂuence of aggregate
shape on encapsulated drug activity) are topics that greatly
merit further research. Overall, this is likely to be a burgeoning





The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
This work was supported by EPSRC grant EP/G067538/1. I
acknowledge the support of a Royal Society-Wolfson Research
Merit Award for work on peptide self-assembly. I am very
grateful to group members and collaborators who have
contributed to our work on PEG−peptide conjugates.
■ REFERENCES
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